AH Bio Fund IV, L.P. is a venture capital fund based in Menlo Park, California. According to its most recent Form D, filed Jan 21, 2022, it has sold $1,500,000,000 of interests to 149 investors since its first sale in Jan 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Ben Horowitz; Marc Andreessen.
- Total raised
- $1,500,000,000Cumulative sales reported on Form D
- Investors
- 149
- First sale
- Jan 7, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Ben Horowitz; Marc Andreessen
- Latest Form D
- Jan 21, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Related vehicles with the same name (2)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| AH Bio Fund IV, L.P. (this page) | $1,500,000,000 | 149 | Jan 21, 2022 |
| AH Bio Fund IV-B, L.P. | $0 | 0 | Jul 1, 2022 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Bainum Family Foundation | DC | $687,023 | fair market value | Jun 30, 2025 |
| Pritzker Foundation | IL | $650,138 | fair market value | Dec 31, 2024 |
| Pritzker Traubert Foundation | IL | $370,078 | fair market value | Dec 31, 2024 |
3 private foundations listed this fund by name among the investments on their IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about AH Bio Fund IV, L.P.
What is the minimum investment for AH Bio Fund IV, L.P.?
AH Bio Fund IV, L.P.'s latest Form D, filed Jan 21, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in AH Bio Fund IV, L.P.?
AH Bio Fund IV, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has AH Bio Fund IV, L.P. raised?
AH Bio Fund IV, L.P. reports $1,500,000,000 sold from 149 investors on its Form D filed Jan 21, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is AH Bio Fund IV, L.P. based?
AH Bio Fund IV, L.P. is based in Menlo Park, California.
When did AH Bio Fund IV, L.P. launch?
AH Bio Fund IV, L.P. reports its first sale in Jan 2022.
Size compared with every venture capital fund
Raised more than 100% of the 2,243 venture capital funds based in California, and more than 100% of all 14,877 that report sales.